Trade Desk, Inc. 8-K

What Happened

• The Trade Desk, Inc. filed an 8-K reporting that board member Kathryn E. Falberg resigned (effective March 23, 2026), leaving the company out of compliance with Nasdaq Listing Rules requiring a minimum of three independent audit committee members and two independent compensation committee members. The company notified Nasdaq on March 24, 2026, and received a Nasdaq notice of noncompliance on March 25, 2026, with a cure period through September 21, 2026.
• Earlier resignations include Alexander Kayyal (effective March 19, 2026). The Board appointed Andrew Vollero on March 21, 2026, to the Board as a Class II director and to the Audit Committee, effective April 3, 2026. Vollero’s appointment is to fill a vacancy tied to a previously announced resignation by Gokul Rajaram.

Key Details

• Nasdaq noncompliance cited: Listing Rules 5605(c)(2)(A) (audit committee minimum three independent directors) and 5605(d)(2)(A) (compensation committee minimum two independent directors); cure deadline: September 21, 2026.
• Resignations: Alexander Kayyal (March 19, 2026) and Kathryn E. Falberg (March 23, 2026); neither resignation was due to a disagreement with the company on operations, policies or practices.
• New director compensation: Andrew Vollero (effective April 3, 2026) will receive $50,000/year for Board service and $12,500/year for Audit Committee service, plus an initial equity grant valued at $290,000 and an annual equity grant of $290,000 (prorated to next annual meeting), with standard vesting; the company will also enter into its standard indemnification agreement with him.
• Separation payment: In connection with Kayyal’s prior separation as CFO, the company agreed to pay a $400,000 relocation amount.

Why It Matters

• Governance and listing risk: The company currently lacks the required independent director composition for key committees, triggering a formal Nasdaq cure period. If Trade Desk does not restore the required committee composition by September 21, 2026, it could face further Nasdaq action, including potential delisting procedures. The company says it intends to fill vacancies promptly.
• Financial and shareholder impact: Appointing a new director restores governance capacity but brings modest ongoing cash fees and equity grants (potential dilution). The $400,000 relocation payment to the former CFO is a one-time cash item disclosed under the separation agreement. Investors should watch for further director appointments and any updates showing restored compliance with Nasdaq committee rules.